J2777 HCPCS Level II Code: Injection, faricimab-svoa, 0.1 mg
Medicare Coverage & Payment
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: October 1, 2022
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Official Registry Overview & Definition
Injection, faricimab-svoa, 0.1 mg is a HCPCS Level II code (J2777). CMS assigns coverage code C — Carrier judgment. Short description: Inj, faricimab-svoa, 0.1mg.
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J2777 in its code family, with their registry titles.
- J2725 — Injection, protirelin, per 250 mcg
- J2730 — Injection, pralidoxime chloride, up to 1 gm
- J2760 — Injection, phentolamine mesylate, up to 5 mg
- J2765 — Injection, metoclopramide hcl, up to 10 mg
- J2770 — Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2778 — Injection, ranibizumab, 0.1 mg
- J2779 — Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
- J2780 — Injection, ranitidine hydrochloride, 25 mg
- J2781 — Injection, pegcetacoplan, intravitreal, 1 mg
- J2782 — Injection, avacincaptad pegol, 0.1 mg